Pub. Date : 2019
PMID : 31360064
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Successful long-term treatment of non-small cell lung cancer positive for RET rearrangement with pemetrexed. | Pemetrexed | ret proto-oncogene | Homo sapiens |
| 2 | We here report a case of NSCLC positive for the CCDC6-RET fusion gene that benefited from treatment with pemetrexed over a period of 30 months, suggesting that thymidylate synthase-targeted drugs such as pemetrexed may show efficacy for NSCLC harboring RET fusions. | Pemetrexed | ret proto-oncogene | Homo sapiens |
| 3 | We here report a case of NSCLC positive for the CCDC6-RET fusion gene that benefited from treatment with pemetrexed over a period of 30 months, suggesting that thymidylate synthase-targeted drugs such as pemetrexed may show efficacy for NSCLC harboring RET fusions. | Pemetrexed | ret proto-oncogene | Homo sapiens |
| 4 | We here report a case of NSCLC positive for the CCDC6-RET fusion gene that benefited from treatment with pemetrexed over a period of 30 months, suggesting that thymidylate synthase-targeted drugs such as pemetrexed may show efficacy for NSCLC harboring RET fusions. | Pemetrexed | ret proto-oncogene | Homo sapiens |
| 5 | We here report a case of NSCLC positive for the CCDC6-RET fusion gene that benefited from treatment with pemetrexed over a period of 30 months, suggesting that thymidylate synthase-targeted drugs such as pemetrexed may show efficacy for NSCLC harboring RET fusions. | Pemetrexed | ret proto-oncogene | Homo sapiens |